A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice

Differential effects of oxyntomodulin and GLP-1 on glucose metabolism

(2012) Xiaobing Du et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Novel insight into glucagon receptor action: lessons from knockout and transgenic mouse models

(2011) P. M. Vuguin et al.   DIABETES OBESITY & METABOLISM

Glucagon antagonism as a potential therapeutic target in type 2 diabetes

(2011) J. I. Bagger et al.   DIABETES OBESITY & METABOLISM

Glucagon-like Peptide–1 Analogues for Type 2 Diabetes Mellitus

(2011) Baptist Gallwitz   DRUGS

Minireview: Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes

(2011) Philip E. Cryer   ENDOCRINOLOGY

DPP-IV-resistant, long-acting oxyntomodulin derivatives

(2011) Alessia Santoprete et al.   JOURNAL OF PEPTIDE SCIENCE

(d-Ser2)Oxm[mPEG-PAL]: A novel chemically modified analogue of oxyntomodulin with antihyperglycaemic, insulinotropic and anorexigenic actions

(2010) Barry D. Kerr et al.   BIOCHEMICAL PHARMACOLOGY

Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents

(2010) Y-L Liu et al.   INTERNATIONAL JOURNAL OF OBESITY

Pancreatic β-cell overexpression of the glucagon receptor gene results in enhanced β-cell function and mass

(2009) Richard W. Gelling et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice

(2009) A. Pocai et al.   DIABETES

A new glucagon and GLP-1 co-agonist eliminates obesity in rodents

(2009) Jonathan W Day et al.   Nature Chemical Biology

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

(2008) P. V. Højberg et al.   DIABETOLOGIA

The Glucagon-Like Peptide-1 Receptor Agonist Oxyntomodulin Enhances β-Cell Function but Does Not Inhibit Gastric Emptying in Mice

(2008) Adriano Maida et al.   ENDOCRINOLOGY

Investigation of Structure-Activity Relationships of Oxyntomodulin (Oxm) Using Oxm Analogs

(2008) Maralyn R. Druce et al.   ENDOCRINOLOGY

KATPChannel Closure Ameliorates the Impaired Insulinotropic Effect of Glucose-Dependent Insulinotropic Polypeptide in Patients with Type 2 Diabetes

(2008) Kasper Aaboe et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM